Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.
Fiche publication
Date publication
mars 2016
Journal
Current opinion in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine
Tous les auteurs :
Antoni D, Mornex F
Lien Pubmed
Résumé
The treatment of locally advanced nonsmall cell lung cancer (NSCLC) is becoming a significant challenge because of a growing proportion of patients with unresectable or potentially eligible for surgery after a multimodality treatment, stage II to III disease. Despite a multimodality approach consisting in concurrent chemoradiotherapy, the prognosis remains poor.
Mots clés
Antineoplastic Agents, therapeutic use, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Carcinoma, Non-Small-Cell Lung, mortality, Chemoradiotherapy, methods, Combined Modality Therapy, methods, Humans, Immunotherapy, methods, Lung Neoplasms, mortality, Molecular Targeted Therapy, methods
Référence
Curr Opin Oncol. 2016 Mar;28(2):104-9